β-Adrenergic Receptor–Stimulated Apoptosis in Cardiac Myocytes Is Mediated by Reactive Oxygen Species/c-Jun NH2-Terminal Kinase–Dependent Activation of the …

A Remondino, SH Kwon, C Communal… - Circulation …, 2003 - Am Heart Assoc
A Remondino, SH Kwon, C Communal, DR Pimentel, DB Sawyer, K Singh, WS Colucci
Circulation research, 2003Am Heart Assoc
Stimulation of β-adrenergic receptors (βARs) causes apoptosis in adult rat ventricular
myocytes (ARVMs). The role of reactive oxygen species (ROS) in mediating βAR-stimulated
apoptosis is not known. Stimulation of βARs with norepinephrine (10 μmol/L) in the
presence of prazosin (100 nmol/L) for 24 hours increased the number of apoptotic myocytes
as determined by TUNEL staining by 3.6-fold. The superoxide dismutase/catalase mimetics
Mn (III) tetrakis (1-methyl-4-pyridyl) porphyrin pentachloride (MnTMPyP; 10 μmol/L) and Euk …
Stimulation of β-adrenergic receptors (βARs) causes apoptosis in adult rat ventricular myocytes (ARVMs). The role of reactive oxygen species (ROS) in mediating βAR-stimulated apoptosis is not known. Stimulation of βARs with norepinephrine (10 μmol/L) in the presence of prazosin (100 nmol/L) for 24 hours increased the number of apoptotic myocytes as determined by TUNEL staining by 3.6- fold. The superoxide dismutase/catalase mimetics Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin pentachloride (MnTMPyP; 10 μmol/L) and Euk-134 decreased βAR-stimulated apoptosis by 89±6% and 76±10%, respectively. Infection with an adenovirus expressing catalase decreased βAR-stimulated apoptosis by 82±15%. The mitochondrial permeability transition pore inhibitor bongkrekic acid (50 μmol/L) decreased βAR-stimulated apoptosis by 76±8%, and the caspase inhibitor zVAD-fmk (25 μmol/L) decreased βAR-stimulated apoptosis by 62±11%. βAR-stimulated cytochrome c release was inhibited by MnTMPyP. βAR stimulation caused c-Jun NH2-terminal kinase (JNK) activation, which was abolished by MnTMPyP. Transfection with an adenovirus expressing dominant-negative JNK inhibited βAR-stimulated apoptosis by 81±12%, and the JNK inhibitor SP600125 inhibited both βAR-stimulated apoptosis and cytochrome c release. Thus, βAR-stimulated apoptosis in ARVMs involves ROS/JNK-dependent activation of the mitochondrial death pathway.
Am Heart Assoc